BASI - Bioanalytical Systems, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue20,44122,69824,584
Cost of Revenue16,01615,20916,622
Gross Profit4,4257,4897,962
Operating Expenses
Research Development496715658
Selling General and Administrative5,9985,8656,596
Non Recurring971971374
Total Operating Expenses---
Operating Income or Loss-3,040909334
Income from Continuing Operations
Total Other Income/Expenses Net195492-909
Earnings Before Interest and Taxes-2,8451,401-575
Interest Expense399287488
Income Before Tax-3,2441,114-1,063
Income Tax Expense-14157
Minority Interest---
Net Income From Continuing Ops-3,2301,099-1,070
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-3,2301,099-1,070
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-3,2301,099-1,070